The Moraga group studies cytokines and their central role in immune regulation. We combine protein engineering, structural biology & immunology in our research

University of Dundee
Joined May 2019
Moraga Lab retweeted
After a hard year, I’m glad to see this finally over the line. A real team effort from ⁦@YiboJin ⁦@scott_d_gardner⁩ ⁦@TomasVoisin and others from ⁦@LabMoraga. As always, amazing data collection support ⁦@eBIC_Diamond⁩ #cryoem ⁦ nature.com/articles/s41467-0…
1
11
42
4,075
Disease-associated variant in IL6ST gene encoding for gp130 led to increased flexibility including motion within the cytokine-binding core (IL-6 and IL-11) and increased distance between extracellular domains nature.com/articles/s41467-0…
2
12
1,200
#Cytokines2023 Metabollix and friends, thanks so much @laoneill111 – at Attiki, Greece
4
1
30
3,078
🚨2 Yr Postdoc Available🚨 Jointly supervised with @scienceadvocacy working on normal and pathological HSCs, cytokines, malignancy, clonal expansion. Come and join us at the newly-formed @CBR_UoY @YBRI_UoY Apply here 👇👇👇jobs.york.ac.uk/vacancy/post… Pls retweet and DM!
22
2
29
6,065
Differential functional coupling in Gp130-JAK complexes expands the plasticity of the interleukin-6 signaling axis biorxiv.org/cgi/content/shor… #bioRxiv
2
2
1,383
📜State-of-the-Art📜 Molecular and cellular factors determining the functional pleiotropy of cytokines 🖋️ By Alison McFarlane, Elizabeth Pohler and Ignacio Moraga from @dundeeuni 🔗 buff.ly/3pWOAme #cytokinesignalling #endosomessignalling
2
8
961
So excited for this session, I couldn’t sleep! Cytokines, engineering, structures, and therapies. Not a session to miss! 10:15 AM-12:15 PM room 102AB
Attending @ImmunologyAAI this week and love cytokines? @CytokineSociety: Modulating Cytokine Activity through Structural Knowledge – Saturday; 10:15 AM – 12:15 PM; Room 102AB. Organized by @DrJuanLMendoza with lots of cool cytokine engineering @SpanglerLab @Regeneron
2
1
6
1,606
Moraga Lab retweeted
Interested in interleukin-6 and how you can therapeutically block its pro-inflammatory activities? See our latest review, just published in @NatRevImmunol — great team work together with @Lab_Jenkins, Stefan Rose-John @kieluni and Jens Moll/Jürgen Scheller @HHU_de
Targeting IL-6 trans-signalling: past, present and future prospects dlvr.it/SmdK7P
2
6
20
4,019
Join us for the ICIS-sponsored and organized session at Immunity 2023! Learn how both academic and industry members of ICIS are advancing our understanding of cytokine biology and developing future immunotherapeutics.
Going to AAI? Please join us for the ICIS Guest Symposium "Understanding and Modulating Cytokine Activity through Structural Knowledge" @DrJuanLMendoza Saturday, May 13; 10:15 AM – 12:15 PM Eastern Time in Room 102AB cytokinesociety.org/understa… via @httpstwittercomCytokineSociety
2
7
545
Going to AAI? Please join us for the ICIS Guest Symposium "Understanding and Modulating Cytokine Activity through Structural Knowledge" @DrJuanLMendoza Saturday, May 13; 10:15 AM – 12:15 PM Eastern Time in Room 102AB cytokinesociety.org/understa… via @httpstwittercomCytokineSociety
4
2
8
4,229
NEW for 2023 on the @SciImmunology website is the dedicated CANCER IMMUNOLOGY block. 🔗➡️bit.ly/Cancer_Immuno Scroll down to it & check out 6 recent #cancerimmunology papers. More exciting new content is on the way to this space soon!
8
33
5,749
Moraga Lab retweeted
#Cancer L’acidité des tumeurs nuit à l’efficacité des thérapies anticancéreuses, selon une nouvelle étude. Des résultats qui pourraient conduire à une nouvelle génération de traitements d’immunothérapie. ➡️bit.ly/3hLyjNq
15
2
40
7,785
Moraga Lab retweeted
SPOTLIGHT: After showing that tumor-derived lactic acid limited IL-2 signaling, STAT5 phosphorylation, and antitumor activity in the TME, @Inserm @at_Mitralab used directed evolution to identify a pH-selective IL-2 mutein that bound IL-2Rα with [...] 👉 ow.ly/QAse50M3ptF
5
16
A new study looks to make IL-2 therapy more effective in tumors, presenting a variant of the cytokine that retains its binding affinity in low pH environments. Read more in @SciImmunology: scim.ag/R5
A new study looks to make IL-2 therapy more effective in tumors, presenting a variant of the cytokine that retains its binding affinity in low pH environments. Read more in @SciImmunology: scim.ag/O8
1
9
2
56
A new study looks to make IL-2 therapy more effective in tumors, presenting a variant of the cytokine that retains its binding affinity in low pH environments. Read more: scim.ag/ME @roychoudhurilab @LabMoraga @at_Mitralab @Inserm @Canther_Lille @CamPathology
11
21
Very interesting paper by my former colleague Suman Mitra @at_Mitralab describing an engineered IL-2 molecule w maintained activity in acidic tumor environments.
An IL-2 variant overcame challenges experienced in low-pH environment of tumors to promote CD8 T cell and NK cell functions in mouse models of melanoma. @roychoudhurilab @LabMoraga @at_Mitralab @Inserm @Canther_Lille @CamPathology 📄: scim.ag/KD
1
7
Our understanding of pH selectivity in immune responses continues to improve. Here is some fascinating work on inherent and engineered IL-2 pH selectivity from @at_Mitralab and colleagues. science.org/doi/10.1126/scii…
2
2